Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tali Eviatar

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Israel Medical Association Journal : IMAJ|May 30, 2019
Paraneoplastic Dactylitis Leading to the Diagnosis of Ovarian CancerTali Eviatar, Ori Elkayam
Rheumatology International|March 11, 2022
Concurrent myopathy and inflammatory cardiac disease in COVID-19 patients: a case series and literature reviewOphir Freund, Tali Eviatar, Gil Bornstein
Scandinavian Journal of Primary Health Care|June 28, 2018
Diabetic Retinopathy -Incidence And Risk Factors In A Community Setting- A Longitudinal StudyMichal Shani, Tali Eviatar, Doron Komaneshter, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 9, 2025
Response to "Refining the Interpretation of Drug Survival and Safety in VEXAS Syndrome: The Importance of Competing Risks and Exposure Time" by Pei Y. et al. and "Reinterpreting the Efficacy of IL-1 Inhibitors in VEXAS Syndrome: A Matter of Superiority or Sequencing?" by Ding Z. et alDafne Capelusnik, Tali Eviatar, Corrado Campochiaro, et al.
Rheumatology (Oxford, England)|July 25, 2024
A novel inhibitory pathway of synovial inflammation exerted by glucocorticoids and tumour necrosis factor inhibitors via lymphocyte activation gene-3 up-regulation: an ex vivo studySmadar Gertel, Ari Polachek, Tali Eviatar, et al.
Rheumatology (Oxford, England)|March 25, 2021
Quality evaluation of the underlying evidence in the updated treatment recommendations for systemic lupus erythematosusYarden Yavne, Yonatan Edel, Julia Berman, et al.
Eye (London, England)|March 29, 2024
Ocular and orbital manifestations in VEXAS syndromeMuhammad Abumanhal, Igal Leibovitch, Michael Zisapel, et al.
European Journal of Internal Medicine|June 4, 2013
Nocardiosis: a 15-year experience in a tertiary medical center in IsraelYossi Rosman, Ehud Grossman, Nathan Keller, et al.
Clinical and Experimental Immunology|May 20, 2024
Cellular immune response to the anti-SARS-CoV-2 BNT162b2 mRNA vaccine in pediatric autoimmune inflammatory rheumatic disease patients and controlsTali Eviatar, Adi Pappo, Tal Freund, et al.
Lupus Science & Medicine|September 24, 2024
Real-world treatment patterns in patients with systemic lupus erythematosus: associations with comorbidities and damageTali Eviatar, Roni Yahalom, Idit Livnat, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Israel Medical Association Journal : IMAJ|May 30, 2019
Paraneoplastic Dactylitis Leading to the Diagnosis of Ovarian CancerTali Eviatar, Ori Elkayam
Rheumatology International|March 11, 2022
Concurrent myopathy and inflammatory cardiac disease in COVID-19 patients: a case series and literature reviewOphir Freund, Tali Eviatar, Gil Bornstein
Scandinavian Journal of Primary Health Care|June 28, 2018
Diabetic Retinopathy -Incidence And Risk Factors In A Community Setting- A Longitudinal StudyMichal Shani, Tali Eviatar, Doron Komaneshter, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 9, 2025
Response to "Refining the Interpretation of Drug Survival and Safety in VEXAS Syndrome: The Importance of Competing Risks and Exposure Time" by Pei Y. et al. and "Reinterpreting the Efficacy of IL-1 Inhibitors in VEXAS Syndrome: A Matter of Superiority or Sequencing?" by Ding Z. et alDafne Capelusnik, Tali Eviatar, Corrado Campochiaro, et al.
Rheumatology (Oxford, England)|July 25, 2024
A novel inhibitory pathway of synovial inflammation exerted by glucocorticoids and tumour necrosis factor inhibitors via lymphocyte activation gene-3 up-regulation: an ex vivo studySmadar Gertel, Ari Polachek, Tali Eviatar, et al.
Rheumatology (Oxford, England)|March 25, 2021
Quality evaluation of the underlying evidence in the updated treatment recommendations for systemic lupus erythematosusYarden Yavne, Yonatan Edel, Julia Berman, et al.
Eye (London, England)|March 29, 2024
Ocular and orbital manifestations in VEXAS syndromeMuhammad Abumanhal, Igal Leibovitch, Michael Zisapel, et al.
European Journal of Internal Medicine|June 4, 2013
Nocardiosis: a 15-year experience in a tertiary medical center in IsraelYossi Rosman, Ehud Grossman, Nathan Keller, et al.
Clinical and Experimental Immunology|May 20, 2024
Cellular immune response to the anti-SARS-CoV-2 BNT162b2 mRNA vaccine in pediatric autoimmune inflammatory rheumatic disease patients and controlsTali Eviatar, Adi Pappo, Tal Freund, et al.
Lupus Science & Medicine|September 24, 2024
Real-world treatment patterns in patients with systemic lupus erythematosus: associations with comorbidities and damageTali Eviatar, Roni Yahalom, Idit Livnat, et al.
Pageof 3